Q8NCG5 (CHST4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 86.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Carbohydrate sulfotransferase 4 EC=2.8.2.- Alternative name(s): Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3 Short name=GST-3 High endothelial cells N-acetylglucosamine 6-O-sulfotransferase Short name=HEC-GlcNAc6ST L-selectin ligand sulfotransferase Short name=LSST N-acetylglucosamine 6-O-sulfotransferase 2 Short name=GlcNAc6ST-2 Short name=Gn6st-2 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 386 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues within mucin-associated glycans that ultimately serve as SELL ligands. SELL ligands are present in high endothelial cells (HEVs) and play a central role in lymphocyte homing at sites of inflammation. Participates in biosynthesis of the SELL ligand sialyl 6-sulfo Lewis X on receptors SPN/CD43, GLYCAM1 and MADCAM1. Also involved in biosynthesis of SELL ligand recognized by MECA-79 antibody. Plays a central role in lymphocyte trafficking during chronic inflammation. Has a catalytic preference for core 2-branched mucin-type O-glycans. Can use GlcNAcbeta1-6[Galbeta1-3]GalNAc-pNP (core 2), GlcNAcbeta1-6ManOMe and GlcNAcbeta1-2Man oligosaccharide structures as acceptors. Has also activity toward core 3 of GlcNAcbeta1-3GalNAc-pNP. Its substrate specificity may be influenced by its subcellular location. Ref.1 |
| Subunit structure | Monomer. Ref.10 |
| Subcellular location | Golgi apparatus membrane; Single-pass type II membrane protein Ref.9. |
| Tissue specificity | Specifically expressed in HEV. Weakly expressed in spleen. Not expressed in other tissues. Expressed in colonic mucinous adenocarcinoma. Ref.1 Ref.6 Ref.7 |
| Induction | Upon cytokine activation, it is expressed at low level. Ref.6 |
| Miscellaneous | May serve as a antiinflammatory target. |
| Sequence similarities | Belongs to the sulfotransferase 1 family. Gal/GlcNAc/GalNAc subfamily. |
| Sequence caution | The sequence AAH35282.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 386 | 386 | Carbohydrate sulfotransferase 4 | PRO_0000085193 | |||||
Regions | |||||||||
| Topological domain | 1 – 7 | 7 | Cytoplasmic Potential | ||||||
| Transmembrane | 8 – 28 | 21 | Helical; Signal-anchor for type II membrane protein; Potential | ||||||
| Topological domain | 29 – 386 | 358 | Lumenal Potential | ||||||
| Nucleotide binding | 51 – 57 | 7 | PAPS By similarity | ||||||
| Nucleotide binding | 205 – 213 | 9 | PAPS By similarity | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 30 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 308 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 329 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 361 | 1 | H → Q. Corresponds to variant rs3813744 [ dbSNP | Ensembl ]. | VAR_052528 | |||||
Experimental info | |||||||||
| Sequence conflict | 225 | 1 | S → N in BAC11177. Ref.4 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin." Bistrup A., Bhakta S., Lee J.K., Belov Y.Y., Gunn M.D., Zuo F.-R., Huang C.-C., Kannagi R., Rosen S.D., Hemmerich S. J. Cell Biol. 145:899-910(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY. Tissue: Tonsil. |
| [2] | "Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase." Yeh J.-C., Hiraoka N., Petryniak B., Nakayama J., Ellies L.G., Rabuka D., Hindsgaul O., Marth J.D., Lowe J.B., Fakuda M. Cell 105:957-969(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Chromosomal localization and genomic organization for the galactose/ N-acetylgalactosamine/N-acetylglucosamine 6-O-sulfotransferase gene family." Hemmerich S., Lee J.K., Bhakta S., Bistrup A., Ruddle N.R., Rosen S.D. Glycobiology 11:75-87(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Tonsil. |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Teratocarcinoma. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [6] | "CHST1 and CHST2 sulfotransferase expression by vascular endothelial cells regulates shear-resistant leukocyte rolling via L-selectin." Li X., Tu L., Murphy P.G., Kadono T., Steeber D.A., Tedder T.F. J. Leukoc. Biol. 69:565-574(2001) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, INDUCTION. |
| [7] | "Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in colonic mucinous adenocarcinoma." Seko A., Nagata K., Yonezawa S., Yamashita K. Glycobiology 12:379-388(2002) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [8] | "Specificities of N-acetylglucosamine-6-O-sulfotransferases in relation to L-selectin ligand synthesis and tumor-associated enzyme expression." Uchimura K., El-Fasakhany F.M., Hori M., Hemmerich S., Blink S.E., Kansas G.S., Kanamori A., Kumamoto K., Kannagi R., Muramatsu T. J. Biol. Chem. 277:3979-3984(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SUBSTRATE SPECIFICITY. |
| [9] | "Golgi localization of carbohydrate sulfotransferases is a determinant of L-selectin ligand biosynthesis." de Graffenried C.L., Bertozzi C.R. J. Biol. Chem. 278:40282-40295(2003) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION. |
| [10] | "The stem region of the sulfotransferase GlcNAc6ST-1 is a determinant of substrate specificity." de Graffenried C.L., Bertozzi C.R. J. Biol. Chem. 279:40035-40043(2004) [PubMed] [Europe PMC] [Abstract] Cited for: SUBUNIT. |
| + | Additional computationally mapped references. |
Web resources
| GGDB GlycoGene database |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF131235 mRNA. Translation: AAD33015.1. AF149783 mRNA. Translation: AAK48417.1. AF280088 mRNA. Translation: AAG48246.1. AK074746 mRNA. Translation: BAC11177.1. BC035282 mRNA. Translation: AAH35282.1. Different initiation. |
| IPI | IPI00301494. |
| RefSeq | NP_001159867.1. NM_001166395.1. NP_005760.1. NM_005769.2. |
| UniGene | Hs.251383. |
3D structure databases | |
| ProteinModelPortal | Q8NCG5. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q8NCG5. 1 interaction. |
| STRING | 9606.ENSP00000341206. |
PTM databases | |
| PhosphoSite | Q8NCG5. |
Polymorphism databases | |
| DMDM | 61211834. |
Proteomic databases | |
| PaxDb | Q8NCG5. |
| PRIDE | Q8NCG5. |
Protocols and materials databases | |
| DNASU | 10164. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000338482; ENSP00000341206; ENSG00000140835. ENST00000539698; ENSP00000441204; ENSG00000140835. ENST00000572450; ENSP00000461839; ENSG00000140835. |
| GeneID | 10164. |
| KEGG | hsa:10164. |
| UCSC | uc002fan.3. human. |
Organism-specific databases | |
| CTD | 10164. |
| GeneCards | GC16P071560. |
| HGNC | HGNC:1972. CHST4. |
| HPA | HPA021955. |
| neXtProt | NX_Q8NCG5. |
| PharmGKB | PA26504. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG80862. |
| HOGENOM | HOG000261614. |
| HOVERGEN | HBG050949. |
| InParanoid | Q8NCG5. |
| KO | K04746. |
| OMA | VEKACRS. |
| OrthoDB | EOG4RXZ09. |
Enzyme and pathway databases | |
| SABIO-RK | Q8NCG5. |
Gene expression databases | |
| Bgee | Q8NCG5. |
| CleanEx | HS_CHST4. |
| Genevestigator | Q8NCG5. |
| GermOnline | ENSG00000140835. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR016469. Carbohydrate_sulfotransferase. IPR000863. Sulfotransferase_dom. [Graphical view] |
| Pfam | PF00685. Sulfotransfer_1. 1 hit. [Graphical view] |
| PIRSF | PIRSF005883. Carbohydrate_sulfotransferase. 1 hit. |
| ProtoNet | Search... |
Other | |
| ChEMBL | CHEMBL2239. |
| GenomeRNAi | 10164. |
| NextBio | 38482. |
Entry information
| Entry name | CHST4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q8NCG5 Secondary accession number(s): Q8IV46, Q9Y5R3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 16 Human chromosome 16: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with
